MENU
GRI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GRI Bio (GRI) Earnings Date & Reports
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders... Show more
A.I. Advisor
published Earnings
GRI is expected to report earnings to fall 7.69% to -83 cents per share on November 13
Q3'26
Est.
$-0.84
Q2'26
Beat
by $0.44
Q1'26
Missed
by $0.65
Q4'25
Missed
by $13.02
Q3'25
Missed
by $1.04
The last earnings report on August 19 showed earnings per share of -91 cents, beating the estimate of -135 cents. With 6.93K shares outstanding, the current market capitalization sits at 3.21M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
2223 Avenida De La Playa
Phone
+1 619 400-1170
Employees
4
Web
https://www.gribio.com